Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial on SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

NCT06155604 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06155604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06155604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial on SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Lead sponsor
The University of Hong Kong
Phase
Phase 2
Overall status
Recruiting
Start date
January 4, 2023
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, lupus nephritis